Dela Cruz, Andreana .
HRN: 25-90-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CLINDAMYCIN 300MG (CAP)
09/23/2024
09/30/2024
PO
300
Q8
Abscess, Right Flank
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes